Org 2766

Known as: L-phenylalanine, gamma-(methylsulfonyl)-L-alpha-aminobutyryl-L-alpha-glutamyl-L-histidyl-L-phenylalanyl-D-lysyl- 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1976-2003
0246819762003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
It has been shown that alphaMSH and the nonmelanotropic ACTH/MSH(4-9) analog ORG 2766 can ameliorate cisplatin-induced… (More)
Is this relevant?
2000
2000
Cisplatin is one of the most potent antineoplastic drugs presently known, but its therapeutic efficacy is seriously limited by… (More)
Is this relevant?
2000
2000
It has been reported that the ACTH-(4-9) analog H-Met(O(2))-Glu-His-Phe-D-Lys-Phe-OH (ORG 2766) administered in adulthood has… (More)
Is this relevant?
1997
1997
OBJECTIVE The objective was to evaluate the efficacy of Org 2766 (a hexapeptide analogue of ACTH) in the prevention or delay of… (More)
Is this relevant?
1994
1994
Prolonged administration of the anti-tumor agent cisplatin may cause a neuropathy in patients. In an animal model, too… (More)
Is this relevant?
1993
1993
Taxol is a novel and promising oncolytic agent the use of which is hampered by its neurotoxicity. We now describe a taxol-induced… (More)
Is this relevant?
1993
1993
A major side effect of cisplatin treatment is peripheral neuropathy. In the past few years we have provided evidence that the… (More)
  • figure 1
  • figure 2
Is this relevant?
1992
1992
Peripheral neuropathy is an important and disabling side-effect of cisplatin treatment. A new drug, Org 2766, has been found to… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
1984
1984
Old (26 months) and young (6 months) male Wistar rats were treated chronically for 2 weeks with ORG 2766 or with vehicle… (More)
Is this relevant?
1981
1981
The actions and interactions of alcohol (1.5 g/kg) and two stimulant peptides were investigated in healthy volunteers. Double… (More)
  • figure 1
  • table 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?